Kyoto, Japan

Masaaki Nonoyama

This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Omron Healthcare Company Ltd., Seiko Epson Corporation. Active years: 2018-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaaki Nonoyama. Retrieved from https://idiyas.com/inventor/masaaki-nonoyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Masaaki Nonoyama

Introduction: Masaaki Nonoyama is a pioneering inventor hailing from Kyoto, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Masaaki Nonoyama holds several patents in the realm of robotics and artificial intelligence, with his most recent inventions focusing on advanced human-machine interfaces and autonomous systems.

Career Highlights: Throughout his illustrious career, Masaaki Nonoyama has been at the forefront of technological advancements, leading research teams and spearheading projects that have revolutionized the way we interact with machines.

Collaborations: Masaaki Nonoyama has collaborated with leading tech companies, research institutions, and universities around the world, working together to push the boundaries of innovation and bring cutting-edge technologies to life.

Conclusion: In conclusion, Masaaki Nonoyama's dedication to innovation and his relentless pursuit of technological excellence have solidified his position as a visionary inventor in the global tech community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…